Clearance Risk Moves Upstream, AI Shifts Execution, and JV Control Gets Rewritten

Clearance Risk Is Moving Upstream in Deal Origination

On 12 October 2026, the European Commission opened a full Phase II review of XXXLutz’s acquisition of Porta, flagging local overlap in Germany, Czechia, and Slovakia, pressure on German discount furniture, and greater supplier dependence through centralized purchasing via GIGA International. The 90-working-day review runs to 25 February 2027, and no public remedy package has emerged. In the US, Albertsons sued Kroger in Delaware over their failed merger, alleging Kroger did not pursue antitrust approval aggressively enough and seeking the $600 million termination fee plus damages reportedly above $9.3 billion.

These disputes show clearance risk is no longer a late-stage legal issue. Australia’s mandatory suspensory regime began on 1 January 2026, the EU is layering merger review with foreign-subsidy and FDI tools, and China’s SAMR is asserting below-threshold call-in authority, including unwinding a completed vertical deal. For deal teams, the work now starts earlier: map approvals by jurisdiction, pressure-test divestiture options before signing, and draft covenants that can survive a failed clearance process.

For practitioners, the edge is in remedy modeling, tighter coordination with antitrust and policy counsel, and documenting clearance efforts well enough to defend valuation, timing, and litigation exposure.

AI Moves M&A Execution From Drafting to Supervision

October 2026 delivered two M&A workflow moves that push AI from search and storage into execution. useABI launched its AI Associate, which ingests an LOI or deal materials, extracts terms, reviews agreements, flags risks and missing information, and generates first-pass purchase-agreement markups, issues lists, diligence reports, executive summaries, supplemental request lists, and transaction checklists. It says a purchase-agreement markup, issues list, diligence report, and diligence summary can be turned around in about 30 minutes, with updates when revised redlines are uploaded.

Datasite also launched an integrated AI M&A platform, extending AI deeper into the virtual data room stack instead of keeping it as a standalone diligence tool. Together, the announcements show the function moving past document management into drafting, review, and workflow automation across early-stage execution.

For deal teams, the practical shift is clear: less time assembling first drafts, more time validating outputs, managing exceptions, and coordinating legal, finance, and business judgment. The edge now comes from spotting where AI is reliable, where it is not, and how quickly you can turn machine output into a defensible deal decision.

Humana’s CenterWell JV Rewrites the Control Package

Humana’s October 13 CenterWell restructuring pushes the story one step further: BlackRock’s HPS Investment Partners will buy WCAS’s roughly $2.8 billion stake, the new JV will be majority-owned by BlackRock, and Humana will keep a minority position while continuing to run the clinics, with a 2028 option to buy JV-owned sites. The deal matters because control, operating rights, and exit options are now being negotiated separately from ownership economics, rather than bundled into a single equity story. That is the next drafting problem emerging from the JV-first structures and Delaware warnings seen last week: governance and future buyback rights are becoming distinct levers that can be priced, traded, and reserved before the valuation is even locked. For corp dev teams, the work is moving still earlier into term-sheet design, where capital commitment, board control, operating authority, and repurchase mechanics have to be set before the purchase agreement starts to harden.